ARCA biopharma, Inc. (ABIO)
-NasdaqCM | Prev Close: | 2.56 |
|---|
| Open: | N/A |
|---|
| Bid: | 2.23 x 700 |
|---|
| Ask: | 2.98 x 500 |
|---|
| 1y Target Est: | 0.50 |
|---|
| Beta: | 2.04 |
|---|
| Next Earnings Date: | 31-May-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 1.38 - 5.94 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 121,624 |
|---|
| Market Cap: | 8.15M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.61 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 13)
- ARCA BIOPHARMA, INC. Files SEC form 8-K/A, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StanEDGAR Online(Thu, May 9)
- ARCA Announces Death of Board Member Burton E. Sobel, Preeminent Physician Scientist and Academic LeaderBusiness Wire(Mon, May 6)
- ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online(Mon, May 6)
- ARCA BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Tue, Apr 23)
- Biogen Idec, Celgene And AbbVie Move To New Highsat Investor's Business Daily(Mon, Apr 22)
- 5 Hot Stocks: GM and Ford Wax Nostalgic, Boeing Readies 787s, and Delhaize Rides Favorable Resultsat Wall St. Cheat Sheet(Mon, Apr 22)
- ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTMBusiness Wire(Mon, Apr 22)
- ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitEDGAR Online(Mon, Apr 22)
- ARCA BIOPHARMA, INC. FinancialsEDGAR Online Financials(Wed, Mar 27)
- ARCA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StandaEDGAR Online(Mon, Mar 25)
- ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Thu, Mar 21)
- A Turnaround Stock Investors Should Loveat Seeking Alpha(Thu, Mar 14)
- CEO of ARCA biopharma to Speak on Changing Paradigms in Drug Development at ACC.13 Conference on March 10, 2013Business Wire(Fri, Mar 8)
- ARCA BIOPHARMA, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial SEDGAR Online(Tue, Mar 5)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-12)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatm...
View More